| ◆ | No clinically significant interaction expected |
| ■ | Potential interaction that may require a dosage adjustment, altered timing of administration, or additional monitoring |
| ● | These drugs should not be co-administered |
| ▲ | Not included in HEP Drug Interactions; however, metabolism and clearance data suggest that an interaction is unlikely |
| ▼ | Not included in HEP Drug Interactions; however, metabolism and clearance data suggest that an interaction may occur |